Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide versus liraglutide for postprandial glucose control in type 2 diabetes
2009-017666-23Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Lixisenatide + metformin with Liraglutide + metformin (2 arms). Primary endpoint: Postprandial plasma glucose AUC. Started May 2010; status: completed.
02
Drugs
lixisenatideliraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-017666-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017666-23.